Renhe Pharmacy Co.,Ltd

000650

CNE000000NF8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
5.9 ^CNY	+0.68%		+0.34%	-11.01%

27/05	Renhe Pharmacy Co.,Ltd Approves Cash Dividend for 2023	CI
23/05	Renhe Pharmacy Gets Nod to Market Oseltamivir Phosphate Capsules	MT

Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.

January 02, 2024 at 09:30 pm IST

From December 7, 2023 to December 31, 2023, the company has repurchased 9,000,000 shares, representing 0.64% for CNY 60.07 million. With this, the company has completed the repurchase of 9,000,000 shares, representing 0.64% for CNY 60.07 million under the buyback announced on December 8, 2023.

Latest news about Renhe Pharmacy Co.,Ltd

Renhe Pharmacy Co.,Ltd Approves Cash Dividend for 2023	28/05	CI
Renhe Pharmacy Gets Nod to Market Oseltamivir Phosphate Capsules	23/05	MT
Renhe Pharmacy Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023	27/04	CI
Renhe Pharmacy Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Renhe Pharmacy Gets 58 Million Yuan in Government Grants	15/04	MT
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.	02/04	CI
Renhe Pharmacy Co., Ltd.'s Equity Buyback announced on December 8, 2023, has closed with 15,500,000 shares, representing 1.11% for CNY 100.01 million.	01/04	CI
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.	02/01	CI
Renhe Pharmacy Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.	07/12	CI
Renhe Pharmacy Co., Ltd. authorizes a Buyback Plan.	07/12	CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/23/29	CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Renhe Pharmacy Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 08 June 2023	02/23/02	CI
Renhe Pharmacy Co., Ltd. Approves Cash Dividend for 2022	01/23/01	CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for 2022	27/23/27	CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/23/25	CI
Renhe Pharmacy Gets Nod Tadalafil Tablets' Registration	06/23/06	MT
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/22/24	CI
Renhe Pharmacy Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on May 27, 2022	21/22/21	CI
Renhe Pharmacy Co., Ltd. Approves Final Cash Dividend for 2021	20/22/20	CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2021	27/22/27	CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI

Chart Renhe Pharmacy Co.,Ltd

Duration

Period

More charts

Company Profile

RENHE PHARMACY CO.,LTD is a China-based company principally engaged in pharmaceutical industry. The Company is mainly engaged in medical industrial manufacturing and medical merchandising. The Companyâs main products include capsules, granules, tablets, powder, injections, suppositories and ointment, among others. The Company is also involved in the wholesaling and retailing of health-related products. The Company distributes its products mainly in domestic market.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
RENHE PHARMACY CO.,LTD	-11.01%	111.61Cr
ELI LILLY AND COMPANY	+56.46%	82TCr
JOHNSON & JOHNSON	-6.46%	35TCr
MERCK & CO., INC.	+18.34%	33TCr
ABBVIE INC.	+9.54%	30TCr
ASTRAZENECA PLC	+16.57%	24TCr
ROCHE HOLDING AG	+2.04%	23TCr
NOVARTIS AG	+13.31%	22TCr
AMGEN INC.	+8.34%	17TCr
PFIZER, INC.	-3.02%	16TCr